Do you want to read an article? Please log in or register.
FIB-4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD
Hepatology
Indications
Related content
Hepatology
Effectiveness of six international guidelines using FIB-4 and FibroScan for risk stratification of MASLD in type 2 diabetes
Clin Gastroenterol Hepatol
Vidal-Trécan T, Julla JB, El Khoury T, Venteclef N, Riveline JP, Paradis V, Valla D, Gautier JF, Castera L
doi: 10.1016/j.cgh.2025.02.018
Hepatology
Effectiveness of a model of care based on Fibrosis-4 and liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease: results from an Italian prospective multicentre study
Am J Gastroenterol
Caviglia GP, Ferro A, D'Ambrosio R, Perbellini R, Lampertico P, Periti G, Valenti L, Ciccioli C, Pennisi G, Petta S, Brodosi L, Petroni ML, Marchignoli F, Pironi L, Sagripanti A, Argenziano ME, Svegliati-Baroni G, Rosso C, Barutta F, Armandi A, Gruden G, Bugianesi E
doi: 10.14309/ajg.0000000000003493
Hepatology
Impact of first and further decompensation in patients with compensated ACLD due to MASLD
J Hepatol
Pennisi G, Di Maria G, Wai-Sun Wong V, de Ledinghen V, Sebastiani G, Viganò M, Fracanzani AL, Miele L, Bugianesi E, Ekstedt M, D'Ambrosio R, Ravaioli F, Schepis F, Marra F, Aghemo A, Svegliati-Baroni G, Persico M, Valenti L, Berzigotti A, George J, Armandi A, Nasr P, Kechagias S, Liguori A, Saltini D, Mendoza YP, Calvaruso V, Enea M, Lin H, Infantino G, Masarone M, Pugliese N, Tulone A, Di Marco V, Cammà C, Petta S
doi: 10.1016/j.jhep.2025.06.014
Hepatology
High inherited risk predicts age-associated increases in fibrosis in patients with MASLD
J Hepatol
Díaz LA, Alazawi W, Agrawal S, Arab JP, Arrese M, Idalsoaga F, Barreyro FJ, Gadano A, Marciano S, Morales JM, Villela-Nogueira C, Leite N, Couto CA, Theodoro R, Joyner de Sousa Dias Monteiro M, Oliveira CP, Pessoa MG, Alvares-da-Silva MR, Madamba E, Bettencourt R, Richards LM, Majithia AR, Khera AV, Loomba R, Ajmera V
doi: 10.1016/j.jhep.2025.04.035
Hepatology
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study
Hepatology
Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar D, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Fernandez MIC, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Alnaamani K, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, The KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Brian Lam PA, Racila A, Alqahtani SA, Stepanova M, Global NASH/MASH Council (GNC)
doi: 10.1097/HEP.0000000000001564
Gastrointestinal Cancer
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study
Lancet Gastroenterol Hepatol
Mahajan UM, Oehrle B, Goni E, Strobel O, Kaiser J, Grützmann R, Werner J, Friess H, Gress TM, Seufferlein TW, Uhl W, Will U, Neoptolemos JP, Wittel UA, Vornhülz M, Sirtl S, Beyer G, Regel I, Boeck S, Heinemann V, Frost F, Steveling A, Völzke H, Petersmann A, Nauck M, Weber E, Kamlage B, Lerch MM, Mayerle J, METAPAC trial investigators
doi: 10.1016/S2468-1253(25)00056-1
Helicobacter Pylori
Seroprevalence of Helicobacter pylori infection among asymptomatic patients served by a safety-net healthcare system
Clin Gastroenterol Hepatol
Thrift AP, Dinarvand P, Juarez L, Brown J, Avila D, Garcia-Villanueva JMZ, Danek LC, Mahmood H, Porter T, Gotschall A, Pirzada NF, Rueda JJ, Lu LB, Ali A, Anyakorah I, Bhattarai SJ, Fatima A, Garcia J, Nguyen HV, Joshi B, Juneja M, Lateef MS, Mujtaba N, Nambi PV, Orr JS, Rahman H, Nguyen S, Waqar A, Chen Y, Graham DY, El-Serag HB, Tan MC
doi: 10.1016/j.cgh.2025.10.005
Further Publications
Evaluating the 2023 EASL guidelines for intrahepatic cholestasis of pregnancy: risk stratification and outcomes in over 4,000 U.S. patients
Am J Gastroenterol
Rodriguez N, Katzenstein C, Alpert L, Sigel K, Sperling RS, Williamson C, Kushner T
doi: 10.14309/ajg.0000000000003866
Inflammatory Bowel Disease
Therapeutic Benefit of Upadacitinib in Severe Post-Proctectomy (Class 4) Perianal Crohn's Disease: A Three-Patient Case Series
Inflamm Bowel Dis
Hanna LN, Quraishi B, Pelly T, Lung P, Tozer P, Hart A, Wong SY, Powell N
doi: 10.1093/ibd/izaf216